1 / 1

Trodelvy Injection 9310090915 at genuine price

Trodelvy 180 mg, with 24% having one dose reduction and 9% with two dose reductions. The most common adverse reaction leading to dose reductions was neutropenia/febrile neutropenia.

roma7
Download Presentation

Trodelvy Injection 9310090915 at genuine price

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Buy Trodelvy Injection 9310090915 at genuine price| The FDA approved medicine Trodelvy is used to treat metastatic triple-negative breast cancer (mTNBC) who have received at least two prior therapies for metastatic disease. Trodelvy comes in 180 mg and 200 mg in single-dose vials to administer intravenously. Trodelvy 200 mg injection contains Sacituzumab govitecan-hziy as an active ingredient and it is a Trop-2 directed antibody and topoisomerase inhibitor conjugate. The recombinant monoclonal antibody is produced by mammalian cells, while the small molecule components SN-38 and CL2A are produced by chemical synthesis. Trodelvy for injection is a sterile, preservative-free, off-white to yellowish lyophilized powder for intravenous use in a 50 mL clear glass single-dose vial, with a rubber stopper and crimp-sealed with an aluminum flip-off cap. Sacituzumab govitecan-hziy is a Trop-2-directed antibody-drug conjugate. Sacituzumab is a humanized antibody that recognizes Trop-2. Sacituzumab is composed of the following three components: •The humanized monoclonal antibody, hRS7 IgG1κ (also called sacituzumab), which binds to Trop-2 • The drug SN-38, a topoisomerase inhibitor • A hydrolysable linker (called CL2A), which links the humanized monoclonal antibody to SN-38. There are several certified Trodelvy suppliers in India, to know more about Trodelvy contact us at 18008891064.

More Related